Rho Capital Partners

Toothio Raises $4M Led By Craft Ventures to Revolutionize Dental Staffing

Retrieved on: 
Wednesday, August 16, 2023

PHOENIX, Aug. 16, 2023 /PRNewswire/ -- Toothio, the on-demand dental staffing platform connecting qualified professionals with practices, today announced a $4 million seed round led by Craft Ventures with participation from Burst Capital, Moving Capital, Revere Partners, and Rho Capital Partners. This investment follows an initial backing from AZ Crown, founders of Insight Enterprises (Nasdaq: NSIT). The capital infusion will be used to accelerate Toothio's growth by enhancing its technology, expanding into key US markets, increasing its network of dental professionals, and adding to its sales team.

Key Points: 
  • "Every dental practice in the US today intimately understands the challenges of staffing the office.
  • Toothio solves this problem by connecting credentialed, friendly dental hygienists, assistants, and receptionists with offices that rely on these important workers," said Jeff Fluhr, co-founder and partner at Craft Ventures.
  • "Dental professionals now prioritize flexible work, the post-pandemic labor market is experiencing unprecedented shortages, and there is a growing demand for dental services.
  • For more information about joining Toothio and its team of marketplace leaders hailing from Amazon, Uber, and Qwik, contact [email protected] .

Stonegate Capital Partners Updates Coverage on Borqs Technologies Inc. (BRQS) 2H 2022

Retrieved on: 
Tuesday, May 30, 2023

Dallas, Texas--(Newsfile Corp. - May 30, 2023) - Borqs Technologies Inc. (NASDAQ: BRQS): Stonegate Capital Partners updates their coverage on Borqs Technologies Inc.

Key Points: 
  • Dallas, Texas--(Newsfile Corp. - May 30, 2023) - Borqs Technologies Inc. (NASDAQ: BRQS): Stonegate Capital Partners updates their coverage on Borqs Technologies Inc.
  • The full report can be accessed by clicking on the following link: https://stonegateinc.com/download/brqs-2h-2022/?wpdmdl=570&refresh=64765...
    To view the full announcement, including downloadable images, bios, and more, click here .
  • Click image above to view full announcement.

Pender Ventures completes $50M first close for Pender Technology Inflection Fund II

Retrieved on: 
Thursday, January 26, 2023

VANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PenderFund Capital Management Ltd. (“Pender”) is pleased to announce a successful first close of $50M for the Pender Technology Inflection Fund II (“PTIF II” or “the Fund”).

Key Points: 
  • VANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PenderFund Capital Management Ltd. (“Pender”) is pleased to announce a successful first close of $50M for the Pender Technology Inflection Fund II (“PTIF II” or “the Fund”).
  • The Fund is managed by Pender Ventures , the technology venture capital arm of Pender.
  • Pender Ventures is targeting $100M for the Fund, and expects to close with additional commitments in the coming months.
  • The Fund’s first close also received capital commitments from BMO Capital Partners, CIBC, Kinsted Wealth, Vancity and Pender Growth Fund Inc.
    “We are thrilled to announce the first close of our second venture fund,” said Maria Pacella, Managing Partner of Pender Ventures.

Elevation Spine, Inc. Closes $11 Million Series B Financing

Retrieved on: 
Monday, September 19, 2022

Elevation Spine, Inc. , the leading innovator of integrated-fixation spinal technologies, today announced the completion of its Series B Preferred Stock financing, totaling $11 million.

Key Points: 
  • Elevation Spine, Inc. , the leading innovator of integrated-fixation spinal technologies, today announced the completion of its Series B Preferred Stock financing, totaling $11 million.
  • Elevation Spine plans to use the proceeds from the financing to ramp the commercial production of Saber-C as well as support product development of future product extensions of the companys Saber Technology platform of products.
  • We are excited to support the Elevation Spine team at this critical growth stage.
  • Elevation Spine welcomes TVP and MCP to our team of investors, said Charles Gilbride, CEO of Elevation Spine.

Evaluate.Market Raises $4M Seed Round

Retrieved on: 
Tuesday, May 17, 2022

Moving forward, we are committed to expanding accessibility, analytical tools and interactive capabilities for the evolving NFT market.

Key Points: 
  • Moving forward, we are committed to expanding accessibility, analytical tools and interactive capabilities for the evolving NFT market.
  • Evaluate.Market has built a crucial, discerning tool for the emerging NFT marketplace, said Dan Ruch, Partner at Rho Capital.
  • Evaluate.Market allows NFT collectors to track and manage their portfolio and discover new projects across multiple NFT marketplaces and blockchains.
  • Evaluate.Market is the leading NFT market management platform that allows collectors to manage their NFT portfolio across wallets, marketplaces, and blockchains.

Flare Capital Partners Announces Close of its Third Fund with $350 Million in Commitments

Retrieved on: 
Tuesday, April 26, 2022

Flare Capital Partners , a leading healthcare technology venture capital firm, today announced the closing of its third fund, Flare Capital Partners III, L.P., with a total of $350 million in committed capital.

Key Points: 
  • Flare Capital Partners , a leading healthcare technology venture capital firm, today announced the closing of its third fund, Flare Capital Partners III, L.P., with a total of $350 million in committed capital.
  • With the most recent fund, this establishes Flare Capital Partners as one of the largest, independent, early-stage venture capital firms dedicated to healthcare technology.
  • Flare Capital Partners strives to help build significant healthcare technology, digital health, and healthcare services companies to improve health outcomes and broaden access while lowering costs of care.
  • Flare Capital is a team of proven healthcare technology investors and senior operating executives known for thought leadership and unparalleled strategic industry resources.

Enerkem closes $255 million financing round to drive its growth and deployment of its leading gasification technology

Retrieved on: 
Wednesday, April 6, 2022

In addition, Monarch Alternative Capital, a new investor, is contributing $30 million to the round while Avenue Capital Group is reinvesting $30 million.

Key Points: 
  • In addition, Monarch Alternative Capital, a new investor, is contributing $30 million to the round while Avenue Capital Group is reinvesting $30 million.
  • Since last year, the company has partnered with Enerkem and Agbar to build Ecoplanta Molecular Solutions in El Morrell, near Tarragona, Spain.
  • "We are pleased to welcome Repsol as a shareholder," said Dominique Boies, Chief Executive Officer of Enerkem.
  • "Repsol is a global multi-energy supplier that will greatly assist in accelerating the deployment of our technology in new markets.

Trialjectory Raises $20 Million to Transform the Cancer Care Industry

Retrieved on: 
Monday, February 7, 2022

Trialjectory is an artificial intelligence (AI)-powered decision-support platform helping to democratize access to advanced cancer treatments.

Key Points: 
  • Trialjectory is an artificial intelligence (AI)-powered decision-support platform helping to democratize access to advanced cancer treatments.
  • Its unique model empowers cancer patients to own their treatment journey by creating a personalized treatment plan that enhances physician point of care.
  • This unique approach continues to successfully remove the barriers and biases that historically prevented cancer patients from accessing advanced treatment options," said Tzvia Bader, Co-Founder and CEO of TrialJectory and a cancer survivor.
  • Trialjectory is an artificial intelligence (AI)-powered decision-support platform democratizing access to advanced cancer treatments.

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member

Retrieved on: 
Tuesday, November 30, 2021

Inflammatix , a pioneering molecular diagnostics company, announced today the appointment of Kian Beyzavi, PhD, as an independent member of the companys board of directors.

Key Points: 
  • Inflammatix , a pioneering molecular diagnostics company, announced today the appointment of Kian Beyzavi, PhD, as an independent member of the companys board of directors.
  • Through her work with multiple stakeholders, Kian has developed a systems-level view of the complex healthcare ecosystem.
  • We are delighted to welcome Kian to the board.
  • Inflammatix is poised to address important unmet needs in the diagnosis of acute illness, which will result in improved treatment decisions and outcomes.

Aren Secures $2 Million In Seed Round

Retrieved on: 
Monday, November 1, 2021

NEW YORK, Nov. 1, 2021 /PRNewswire-PRWeb/ -- Aren the leading civil infrastructure management Software-as-a-Service (SaaS) platformtoday announced its seed capital raise of $2 million, aimed at growing its engineering and product teams as the company scales.

Key Points: 
  • NEW YORK, Nov. 1, 2021 /PRNewswire-PRWeb/ -- Aren the leading civil infrastructure management Software-as-a-Service (SaaS) platformtoday announced its seed capital raise of $2 million, aimed at growing its engineering and product teams as the company scales.
  • The round was led by Shadow Ventures, with Rho Capital Partners, MetaProp, Technion Angels, Green Egg Ventures, HBS Alumni Angels, Turf Advisory, COINS, and Maccabee Ventures as major participants.
  • Preserving infrastructure is the core foundation of Aren.
  • Aren is building a civil infrastructure management platform for engineering firms and asset owners to minimize the risk of failure and optimize infrastructure spending.